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Introduction: DIOS syndrome in patients with CF occurs with a frequency of 6.2/
1000 patients/year, mainly in adolescents and young adults. It is extremely rare in
younger children. Known risk factors for DIOS include: meconium obstructions in
the neonatal period, abnormal enzyme supplementation, dietary errors, dehydration
and others.
Objective: Analysis of the clinical assessment of risk factors for DIOS syndrome
in an 11-month-old infant suffering from cystic ﬁbrosis.
Material and Methods: We present a case of DIOS in an 11-month-old female
infant diagnosed with CF by newborn screening test. The baby was referred to
the district hospital because of febrile conditions, reduction in ﬂuid consumption
and eating, and ion disorders. On admission the child had features of dehydration
and bloated belly with lazy motility. Additional examination revealed high rates of
inﬂammation, electrolyte disturbances, hypoproteinaemia, and high rates of acidic
steatocrit. Despite the persistence of observed treatment of infections parameters,
growth of abdominal circumference, disposable vomiting. The diagnostic imaging
studies, including the intestinal passage, showed retention of contrast around the
ileocaecal bowel. Child consulted surgery. Oral feeding was stopped, starting
rectal infusions of N-acetylcysteine, irrigation, included metronidazole, standard
realimentation with enzyme supplementation. Improvement in clinical status was
obtained.
Conclusions:
1. Avoidance and effective treatment of states of dehydration and the proper enzyme
supplementation may reduce the risk for DIOS syndrome in infants.
2. Coexistence of several risk factors in the same child greatly increases the risk
of developing ovarian DIOS.
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Objectives: To describe the diagnostic and treatment course of 4 cystic ﬁbrosis
patients with unusual and potentially fatal thrombotic and thromboembolic compli-
cations of indwelling central venous access systems.
Methods: Patient demographics, histories, biochemical data and imaging were
compiled retrospectively through in-patient hospital documentation and hospital
laboratory and radiological systems. Cardiology data was obtained from echocardio-
graphy reports and vascular data was obtained from pulmonary catheter laboratory
reports.
Conclusions: This novel case series addresses several important diagnostic and
therapeutic issues arising from the hypercoagulability of cystic ﬁbrosis patients and
their need for long-term venous access. In addition to discussing the potentially
fatal complications of indwelling central venous access devices, this case series
also highlights an emerging challenge arising from the improved life expectancy of
cystic ﬁbrosis patients today.
